Lowered norepinephrine turnover as a sign of impaired ganglionic transmission after preganglionic lesioning by acetylcholinesterase antibodies

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 817-822

  Mckinzie, Sanna ^a   Tyce, Gertrude M ^a   Brimijoin, Stephen ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; MICROELECTRODE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SALIVARY GLAND; SYMPATHETIC TONE; SYNAPTIC TRANSMISSION; TURNOVER TIME;

ACETYLCHOLINESTERASE; ANIMALS; ANTIBODIES, MONOCLONAL; COLD; GANGLIA, SYMPATHETIC; GANGLIONIC BLOCKERS; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

EID: 0030436625     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ALOUSI, A. AND WEINER, N.: The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents. Proc. Natl. Acad Sci. U.S.A. 56: 1491-1496, 1966
2. 3-norepinephrine release by monoamine oxidase inhibitors. J. Pharmacol. Exp. Ther. 134: 325-328, 1961.
3. BRIMIJOIN, S.: Using antibodies to unwire the sympathetic nervous system. News Physiol. Science. 10: 101-106, 1995.
4. BRIMIJOIN, S., DAGERLIND, Å., RAO, R., MCKINZIE, S. AND HAMMOND, P.: Accumulation of enkephalin, proenkephalin mRNA, and neuropeptide Y in immunologically denervated rat adrenal glands: Evidence for divergent peptide regulation. J. Neurochem. 64: 1281-1287, 1995.
5. BRIMIJOIN, S., HAMMOND, P., KHRAIBI, A. A. AND TYCE, G. M.: Catecholamine release and excretion in rats with immunologically induced preganglionic sympathectomy. J. Neurochem. 62: 2195-2204, 1994.
6. BRIMIJOIN, S. AND LENNON, V. A.: Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc. Natl Acad. Sci. U.S.A. 87: 9630-9634, 1990.
7. BRIMIJOIN, S., MOSER, V., HAMMOND, P., OKA, N. AND LENNON, V. A.: Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of peripheral preganglionic sympathetic terminals by acetylcholinesterase antibodies. Neuroscience 54: 201-223, 1993.
8. BRODIE, B. B., COSTA, E., DLABAC, A., NEFF, N. H. AND SMOOKLER, H. H.: Application of steady-state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 154: 493-498, 1966.
9. BURACK, W. R. AND DRASKÓCZY, P. R.: The turnover of endogenously labeled catecholamine in several regions of the sympathetic nervous system. J Pharmacol. Exp. Ther. 144: 66-75, 1964.
10. COSTA, E. AND NEFF, N. H.: Isotopic and nonisotopic measurements of catecholamine biosynthesis. In Biochemistry and Pharmacology of the Basal Ganglia, ed. by E. Costa, L. Cote and M. D. Yahr, pp. 141-156, Raven Press, New York, 1966.
11. DOUSA, M. K. AND TYCE, G. M.: Free and conjugated plasma catecholamines, DOPA and 3-O-methyldopa in humans and in various animal species. Proc. Soc. Exp. Biol. Med. 188: 427-434, 1988.
12. EISENHOFER, G., ROPCHAK, T. G., KOPIN, I. J. AND GOLDSTEIN, D. S.: Release, metabolism and intraneuronal disposition of exogenous, endogenous, and newly synthesized norepinephrine in the rat vas deferens. J. Pharmacol. Exp. Ther. 245: 81-88, 1988.
13. FRANK, M. M. AND FRIES, L. F.: Complement. In Fundamental Immunology, ed by W. E. Paul, pp. 679-701, Raven Press, New York, 1989.
14. 3-norepinephrine J. Pharmacol. Exp. Ther. 136: 289-292, 1962.
15. LEDUC, J.: Catecholamine production and release in exposure and acclimation to cold. Acta Physiol. Scand. 53: suppl 183, 1-101, 1961.
16. MAAS, J. W., BENENSOHN, H. AND LANDIS, D H.: A kinetic study of the disposition of circulating norepinephrine in normal male subjects. J. Pharmacol. Exp Ther. 174: 381-387, 1970.
17. MCKINNEY, M. M. AND PARKINSON, A.: A simple, non-chromatographic, procedure to purify inununoglobulins from serum and ascites fluid. J. Immunol. Methods 96: 271-278, 1987.
18. MONTANARI, R., COSTA, E., BEAVEN, M. A. AND BRODIE, B. B.: Turnover rates of norepinephrine in hearts of intact mice, rats and guinea pigs using tritiated norepinephrine. Life Sci. 4: 232-240, 1963.
19. MOURA, D., AZEVEDO, I. AND GUIMARAES, S.: Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines Naunyn-Schmiedebergs Arch. Pharmacol. 342: 153-159, 1990.
20. NEFF, N. H. AND COSTA, E.: Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration. J. Pharmacol. Exp. Ther. 160: 40-47, 1968.
21. OLIVERIO, A. AND STJARNE, L.: Acceleration of noradrenaline turnover in the mouse heart by cold exposure. Life Sci. 4: 2239-2343, 1965.
22. RAKONCZAY, Z. AND BRIMIJOIN, S.: Monoclonal antibodies to rat brain acetylcholinesterase: comparative affinity for soluble and membrane-associated enzyme and for enzyme from different vertebrate species. J. Neurochem. 46: 280-287, 1986.
23. 14C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. Acta Pharmacol. Toxicol. 36: 395-408, 1975.
24. SEDVALL, G. C. AND KOPIN, I. J.: Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sci. 6: 45-51, 1967.
25. VON EULER, U. S. AND HELLNER-BJORKMAN, S.: Effect of increased adrenergic activity on the content of noradrenaline and adrenaline in cat organs Acta Physiol. Scand. 33: 17-20, 1955.